Results 1 to 10 of about 7,022 (190)

Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib [PDF]

open access: goldFrontiers in Immunology, 2021
The Janus kinases (JAKs) are intracellular tyrosine kinases involved in a broad variety of inflammatory cascades participating in the pathogenesis of systemic lupus erythematosus (SLE).
Yu-Lan Chen   +5 more
doaj   +4 more sources

Asynchronous Teledermatology for Non-Scarring Alopecia: A Retrospective Study [PDF]

open access: goldTelemedicine Reports
Background: Non-scarring alopecia, including androgenetic alopecia (AGA), alopecia areata (AA), telogen effluvium (TE), and traction alopecia (TA), significantly impacts psychosocial well-being.
Aliyyat Afolabi   +3 more
doaj   +3 more sources

Giant Morpheaform Basal Cell Carcinoma Mimicking Scarring Alopecia: Exception Prone to Neglect [PDF]

open access: goldDermatopathology
A 74-year-old woman in good general health presented with a 5-year history of progressive hair loss over several years, interpreted as female androgenetic alopecia (AGA), and was treated with topical 5% Minoxidil without improvement.
Carlo Francesco Tomasini   +4 more
doaj   +4 more sources

Research progress in the treatment of non-scarring alopecia: mechanism and treatment [PDF]

open access: goldFrontiers in Pharmacology
IntroductionNon-scarring alopecia, encompassing androgenetic alopecia (AGA), alopecia areata (AA), and telogen effluvium (TE), is a common skin condition that significantly impacts both the physical and psychological wellbeing of affected individuals ...
Rui-Xian Guo   +9 more
doaj   +3 more sources

Scarring alopecia and scalp pruritus [PDF]

open access: yesJAAD Case Reports, 2022
Catherine Barker, BS   +3 more
doaj   +4 more sources

Scarring alopecia and the dermatopathologist [PDF]

open access: bronzeJournal of Cutaneous Pathology, 2001
Background: The evaluation of patients with cicatricial alopecia is particularly challenging, and dermatopathologists receive little training in the interpretation of scalp biopsy specimens. Accurate interpretation of specimens from patients with hair disease requires both qualitative (morphology of follicles, inflammation, fibrosis, etc.) and ...
Leonard C. Sperling
openalex   +4 more sources

Psoriatic scarring alopecia [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2013
Psoriasis is a relatively frequent inflammatory dermatosis. Scarring alopecia due to scalp psoriasis was first reported in 1972, but few reports have been written since then, showing that this is a very rare complication of a common disorder. We report a
Maiana Carneiro Almeida   +4 more
doaj   +5 more sources

Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus [PDF]

open access: yesArthritis Research & Therapy, 2021
Background Scarring alopecia in systemic lupus erythematosus (SLE) patients caused reduced life quality and prolonged disease course. This case-control study aims to survey the prevalence of scarring alopecia during the disease course of SLE and evaluate
Yirong Xiang   +22 more
doaj   +2 more sources

Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia [PDF]

open access: yesPharmaceutics, 2022
Alopecia or baldness is a common diagnosis in clinical practice. Alopecia can be scarring or non-scarring, diffuse or patchy. The most prevalent type of alopecia is non-scarring alopecia, with the majority of cases being androgenetic alopecia (AGA) or ...
Talagavadi Channaiah Anudeep   +8 more
doaj   +2 more sources

Erythroderma with total scarring alopecia. [PDF]

open access: yesBMJ Case Rep, 2023
A woman in her 50s presented with total scarring ulcerated alopecia evolving for 10 years, and a recent budding tumour on the lower lip. Clinical examination revealed an associated exfoliated and infiltrated erythroderma with ulcerated cutaneous tumours of the legs, palmoplantar hyperkeratosis, hepatosplenomegaly and diffuse lymphadenopathies.
Karrakchou B   +3 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy